Medical Countermeasures U.S. Replenishes Smallpox and Mpox Vaccine Stockpile in $52.7 Million Contract AwardGlobal Biodefense StaffJune 29, 2026
Medical Countermeasures WHO Launches Clinical Trial of Two Experimental Ebola Treatments in DRCGlobal Biodefense StaffJune 25, 2026
Medical Countermeasures Experimental Two-in-One Vaccine Shows Early Promise Against Lassa Fever and RabiesGlobal Biodefense StaffJune 19, 2026
Top Pharma and Research Institutes Partner for ‘TB Drug Accelerator’ Medical Countermeasures June 27, 2012 …
Emergent Biosolutions, Novartis, Texas A&M to Lead New Biodefense Centers Contracts + Grants June 19, 2012 …
